Literature DB >> 29188641

[Role of CCL5/CCR5 in the perineural invasion of salivary adenoid cystic carcinoma cells].

Li Tianyi1, Shen Zhiyuan2.   

Abstract

OBJECTIVE: This study aimed the role of the CCL5/CCR5 axis in the perineural invasion of salivary adenoid cystic carcinoma (SACC) cells.
METHODS: Immunohistochemical analysis and flow cytometric analysis were conducted to detect the expression of the chemokine receptor CCR5 in SACC cells. Enzyme linked immunosorbent assay (ELISA) was performed to determine the expression of CCL5 in the supernate of human nerve cells. The flow cytometric analysis was applied to observe the changes in F-actin in SACC-LM cells, which were pretreated with CCL5. To assess the effects of the CCL5/CCR5 axis on the migration and invasion of SACC-LM cells, we performed a scratch test and invasion assay under CCL5 stimulation.
RESULTS: CCR5 was highly expressed in SACC cells. The concentration of CCL5 in the supernatant of human nerve cells was (359.2±15.8), (696.4±22.6) pg·mL⁻¹. The CCL5/CCR5 axis promoted the migration and invasion of SACC-LM cells.
CONCLUSIONS: The CCL5/CCR5 axis may be involved in the perineural invasion of SACC cells.

Entities:  

Keywords:  CCL5; CCR5; perineural invasion; salivary adenoid cystic carcinoma; salivary glands

Mesh:

Substances:

Year:  2017        PMID: 29188641      PMCID: PMC7030399          DOI: 10.7518/hxkq.2017.05.006

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  15 in total

Review 1.  Perineural invasion and spread in head and neck cancer.

Authors:  Meredith Johnston; Eugene Yu; John Kim
Journal:  Expert Rev Anticancer Ther       Date:  2012-03       Impact factor: 4.512

Review 2.  The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Authors:  Neora Yaal-Hahoshen; Sima Shina; Leonor Leider-Trejo; Itay Barnea; Esther L Shabtai; Elina Azenshtein; Iulia Greenberg; Iafa Keydar; Adit Ben-Baruch
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

Review 3.  Chemokines and chemokine receptors: positioning cells for host defense and immunity.

Authors:  Jason W Griffith; Caroline L Sokol; Andrew D Luster
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

4.  Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

Authors:  J A Burger; M Burger; T J Kipps
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

5.  The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

Authors:  Elina Azenshtein; Galia Luboshits; Sima Shina; Eran Neumark; David Shahbazian; Miguel Weil; Nely Wigler; Iafa Keydar; Adit Ben-Baruch
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

Review 6.  Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator?

Authors:  A William Barrett; Paul M Speight
Journal:  Oral Oncol       Date:  2009-08-18       Impact factor: 5.337

Review 7.  Perineural invasion in cancer: a review of the literature.

Authors:  Catherine Liebig; Gustavo Ayala; Jonathan A Wilks; David H Berger; Daniel Albo
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

8.  Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization.

Authors:  Shigeo Yoshida; Ayako Yoshida; Tatsuro Ishibashi; Susan G Elner; Victor M Elner
Journal:  J Leukoc Biol       Date:  2003-01       Impact factor: 4.962

9.  Association of chemotactic factor receptor 5 gene with breast cancer.

Authors:  Y Zhang; F Y Meng; W L Li; C X Zhou; Z Guan; H Y Fan
Journal:  Genet Mol Res       Date:  2013-11-07

Review 10.  Targeting CCL5 in inflammation.

Authors:  Rafael Elias Marques; Rodrigo Guabiraba; Remo Castro Russo; Mauro Martins Teixeira
Journal:  Expert Opin Ther Targets       Date:  2013-10-03       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.